Related Experiment Video
Updated: Jun 30, 2026

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients
Published on: February 11, 2017
Disease severity associated with cystic fibrosis mutations deltaF508 and S549R(T-->G)
K P Dawson1, P M Frossard, B Al-Awar
1Department of Paediatrics, Faculty of Medicine and Health Science, UAE University, Al-Ain, United Arab Emirates.
Insights
The cystic fibrosis (CF) mutations S549R(T-->G) and deltaF508 present similarly severe clinical symptoms in children. These CF mutations result in comparable illness severity, making them indistinguishable based on clinical presentation.
Area of Science:
- Medical Genetics
- Pediatrics
- Pulmonology
Background:
- Cystic Fibrosis (CF) is a genetic disorder affecting multiple organs.
- Specific CFTR gene mutations influence disease severity.
- Understanding mutation-specific clinical presentations is crucial for patient management.
Purpose of the Study:
- To compare the clinical severity of two distinct cystic fibrosis mutations: S549R(T-->G) and deltaF508.
- To evaluate clinical and biochemical variables in children with these CF mutations in the United Arab Emirates (UAE).
Main Methods:
- Comparative analysis of clinical and biochemical data.
- Age- and sex-matched cohorts of pediatric CF patients in the UAE.
- Assessment of Shwachman scores and sweat chloride levels.
Main Results:
- Both S549R(T-->G) and deltaF508 homozygous mutations exhibited severe clinical phenotypes.
- Patients displayed comparable very low Shwachman scores, indicating significant pancreatic insufficiency.
- High sweat chloride levels were observed in both groups, consistent with CF diagnosis.
Conclusions:
- The CF mutations deltaF508 and S549R(T-->G) lead to indistinguishable severe clinical presentations.
- Homozygous patients for these mutations show comparable disease severity on clinical grounds.
- This finding aids in understanding genotype-phenotype correlations in cystic fibrosis.
Abstract:
We compared the clinical severity associated with the two cystic fibrosis (CF) mutations S549R(T-->G) and deltaF508. Clinical and biochemical variables of CF were compared in two age- and sex-matched groups of CF children in the United Arab Emirates (UAE). The clinical severity of mutations S549R(T-->G) and deltaF508 showed comparable patterns, with very low Shwachman scores and high sweat chloride levels. We conclude that patients homozygous for the CF mutations deltaF508 and S549R(T-->G) have a severe clinical presentation and illness and are indistinguishable on clinical grounds.
More Related Videos
08:00Generation of Human Nasal Epithelial Cell Spheroids for Individualized Cystic Fibrosis Transmembrane Conductance Regulator Study
Published on: April 11, 2018
05:56Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis
Published on: August 29, 2025
Related Concept Videos
Mutations
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Translation
Translation is the process of synthesizing proteins from the genetic information carried by messenger RNA (mRNA). Following transcription, it constitutes the final step in the expression of genes. This process is carried out by ribosomes, complexes of protein and specialized RNA molecules. Ribosomes, transfer RNA (tRNA), and other proteins produce a chain of amino acids—the polypeptide—as the end product of translation.
Translation Produces the Building Blocks of Life
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management
Sinus disease and chronic sinusitis...
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features